Martha Thomas

Statistics

Publications

Citations

139

H-Index

Active since

2015

Affiliations

University of Virginia(Current)

Martha Thomas is an author at University of Virginia specializing in complement system dysregulation, tumor suppressor loss, and rituximab-based therapy.

ORCID

Publications per year

2015–2021

Publications

Clinicopathologic Comparison of Lynch Syndrome–associated and “Lynch-like” Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry

Anne M. Mills, Emily A. Sloan, Martha Thomas et al. · The American Journal of Surgical Pathology · 2015 · 78 citations

Medicine, Oncology, Pathology +17

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status

Brett Kurpiel, Martha Thomas, Mansoor Mubeen et al. · International Journal of Gynecological Pathology · 2021 · 11 citations

Medicine, Genetics, Oncology +17

Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution’s high-risk population

A Meiss, Martha Thomas, Susan C. Modesitt et al. · Human Pathology · 2018 · 10 citations

Medicine, Oncology, Pathology +17

1–4 of 4